2024-01-012024-12-312024-12-31false09044389BEDALE DAY NURSERY LIMITED2025-08-1588910falseiso4217:GBPxbrli:pure090443892023-12-31090443892024-12-31090443892024-01-012024-12-31090443892022-12-31090443892023-12-31090443892023-01-012023-12-3109044389bus:SmallEntities2024-01-012024-12-3109044389bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3109044389bus:FullAccounts2024-01-012024-12-3109044389bus:PrivateLimitedCompanyLtd2024-01-012024-12-3109044389core:WithinOneYear2024-12-3109044389core:AfterOneYear2024-12-3109044389core:WithinOneYear2023-12-3109044389core:AfterOneYear2023-12-3109044389core:ShareCapital2024-12-3109044389core:SharePremium2024-12-3109044389core:RevaluationReserve2024-12-3109044389core:OtherReservesSubtotal2024-12-3109044389core:RetainedEarningsAccumulatedLosses2024-12-3109044389core:ShareCapital2023-12-3109044389core:SharePremium2023-12-3109044389core:RevaluationReserve2023-12-3109044389core:OtherReservesSubtotal2023-12-3109044389core:RetainedEarningsAccumulatedLosses2023-12-3109044389core:LandBuildings2024-12-3109044389core:PlantMachinery2024-12-3109044389core:Vehicles2024-12-3109044389core:FurnitureFittings2024-12-3109044389core:OfficeEquipment2024-12-3109044389core:NetGoodwill2024-12-3109044389core:IntangibleAssetsOtherThanGoodwill2024-12-3109044389core:ListedExchangeTraded2024-12-3109044389core:UnlistedNon-exchangeTraded2024-12-3109044389core:LandBuildings2023-12-3109044389core:PlantMachinery2023-12-3109044389core:Vehicles2023-12-3109044389core:FurnitureFittings2023-12-3109044389core:OfficeEquipment2023-12-3109044389core:NetGoodwill2023-12-3109044389core:IntangibleAssetsOtherThanGoodwill2023-12-3109044389core:ListedExchangeTraded2023-12-3109044389core:UnlistedNon-exchangeTraded2023-12-3109044389core:LandBuildings2024-01-012024-12-3109044389core:PlantMachinery2024-01-012024-12-3109044389core:Vehicles2024-01-012024-12-3109044389core:FurnitureFittings2024-01-012024-12-3109044389core:OfficeEquipment2024-01-012024-12-3109044389core:NetGoodwill2024-01-012024-12-3109044389core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3109044389core:ListedExchangeTraded2024-01-012024-12-3109044389core:UnlistedNon-exchangeTraded2024-01-012024-12-3109044389core:MoreThanFiveYears2024-01-012024-12-3109044389core:Non-currentFinancialInstruments2024-12-3109044389core:Non-currentFinancialInstruments2023-12-3109044389dpl:CostSales2024-01-012024-12-3109044389dpl:DistributionCosts2024-01-012024-12-3109044389core:LandBuildings2024-01-012024-12-3109044389core:PlantMachinery2024-01-012024-12-3109044389core:Vehicles2024-01-012024-12-3109044389core:FurnitureFittings2024-01-012024-12-3109044389core:OfficeEquipment2024-01-012024-12-3109044389dpl:AdministrativeExpenses2024-01-012024-12-3109044389core:NetGoodwill2024-01-012024-12-3109044389core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3109044389dpl:GroupUndertakings2024-01-012024-12-3109044389dpl:ParticipatingInterests2024-01-012024-12-3109044389dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3109044389core:ListedExchangeTraded2024-01-012024-12-3109044389dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3109044389core:UnlistedNon-exchangeTraded2024-01-012024-12-3109044389dpl:CostSales2023-01-012023-12-3109044389dpl:DistributionCosts2023-01-012023-12-3109044389core:LandBuildings2023-01-012023-12-3109044389core:PlantMachinery2023-01-012023-12-3109044389core:Vehicles2023-01-012023-12-3109044389core:FurnitureFittings2023-01-012023-12-3109044389core:OfficeEquipment2023-01-012023-12-3109044389dpl:AdministrativeExpenses2023-01-012023-12-3109044389core:NetGoodwill2023-01-012023-12-3109044389core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3109044389dpl:GroupUndertakings2023-01-012023-12-3109044389dpl:ParticipatingInterests2023-01-012023-12-3109044389dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3109044389core:ListedExchangeTraded2023-01-012023-12-3109044389dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3109044389core:UnlistedNon-exchangeTraded2023-01-012023-12-3109044389core:NetGoodwill2024-12-3109044389core:IntangibleAssetsOtherThanGoodwill2024-12-3109044389core:LandBuildings2024-12-3109044389core:PlantMachinery2024-12-3109044389core:Vehicles2024-12-3109044389core:FurnitureFittings2024-12-3109044389core:OfficeEquipment2024-12-3109044389core:AfterOneYear2024-12-3109044389core:WithinOneYear2024-12-3109044389core:ListedExchangeTraded2024-12-3109044389core:UnlistedNon-exchangeTraded2024-12-3109044389core:ShareCapital2024-12-3109044389core:SharePremium2024-12-3109044389core:RevaluationReserve2024-12-3109044389core:OtherReservesSubtotal2024-12-3109044389core:RetainedEarningsAccumulatedLosses2024-12-3109044389core:NetGoodwill2023-12-3109044389core:IntangibleAssetsOtherThanGoodwill2023-12-3109044389core:LandBuildings2023-12-3109044389core:PlantMachinery2023-12-3109044389core:Vehicles2023-12-3109044389core:FurnitureFittings2023-12-3109044389core:OfficeEquipment2023-12-3109044389core:AfterOneYear2023-12-3109044389core:WithinOneYear2023-12-3109044389core:ListedExchangeTraded2023-12-3109044389core:UnlistedNon-exchangeTraded2023-12-3109044389core:ShareCapital2023-12-3109044389core:SharePremium2023-12-3109044389core:RevaluationReserve2023-12-3109044389core:OtherReservesSubtotal2023-12-3109044389core:RetainedEarningsAccumulatedLosses2023-12-3109044389core:NetGoodwill2022-12-3109044389core:IntangibleAssetsOtherThanGoodwill2022-12-3109044389core:LandBuildings2022-12-3109044389core:PlantMachinery2022-12-3109044389core:Vehicles2022-12-3109044389core:FurnitureFittings2022-12-3109044389core:OfficeEquipment2022-12-3109044389core:AfterOneYear2022-12-3109044389core:WithinOneYear2022-12-3109044389core:ListedExchangeTraded2022-12-3109044389core:UnlistedNon-exchangeTraded2022-12-3109044389core:ShareCapital2022-12-3109044389core:SharePremium2022-12-3109044389core:RevaluationReserve2022-12-3109044389core:OtherReservesSubtotal2022-12-3109044389core:RetainedEarningsAccumulatedLosses2022-12-3109044389core:AfterOneYear2024-01-012024-12-3109044389core:WithinOneYear2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3109044389core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3109044389core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3109044389core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3109044389core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3109044389core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3109044389core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3109044389core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3109044389core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3109044389core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3109044389core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3109044389core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3109044389core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3109044389core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3109044389core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3109044389core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3109044389core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3109044389core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3109044389core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3109044389bus:Director12024-01-012024-12-3109044389bus:Director22024-01-012024-12-3109044389bus:Director32024-01-012024-12-31

BEDALE DAY NURSERY LIMITED

Registered Number
09044389
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

BEDALE DAY NURSERY LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

BIRKBECK, Maxine Claire
COCKS, George Edger William
COCKS, Harriett Victoria Rose

Registered Address

York House Thornfield Business Park
Standard Way Business Park
Northallerton
DL6 2XQ

Registered Number

09044389 (England and Wales)
BEDALE DAY NURSERY LIMITED
Statement of Financial Position
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets42,5747,590
2,5747,590
Current assets
Debtors5153,957156,379
Cash at bank and on hand2,30029,072
156,257185,451
Creditors amounts falling due within one year6(131,342)(158,573)
Net current assets (liabilities)24,91526,878
Total assets less current liabilities27,48934,468
Creditors amounts falling due after one year7(19,775)(30,704)
Net assets7,7143,764
Capital and reserves
Called up share capital200200
Profit and loss account7,5143,564
Shareholders' funds7,7143,764
The financial statements were approved and authorised for issue by the Board of Directors on 15 August 2025, and are signed on its behalf by:
BIRKBECK, Maxine Claire
Director
Registered Company No. 09044389
BEDALE DAY NURSERY LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Land and buildings-10
Plant and machinery25-
Vehicles25-
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
The company enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
2.Average number of employees

20242023
Average number of employees during the year1621
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 January 24160,000160,000
At 31 December 24160,000160,000
Amortisation and impairment
At 01 January 24160,000160,000
At 31 December 24160,000160,000
Net book value
At 31 December 24--
At 31 December 23--
4.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Total

££££
Cost or valuation
At 01 January 2494,8399,04941,700145,588
At 31 December 2494,8399,04941,700145,588
Depreciation and impairment
At 01 January 2490,6818,48738,830137,998
Charge for year4,1581417175,016
At 31 December 2494,8398,62839,547143,014
Net book value
At 31 December 24-4212,1532,574
At 31 December 234,1585622,8707,590
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables1,7691,807
Other debtors150,395152,029
Prepayments and accrued income1,7932,543
Total153,957156,379
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables4,3556,361
Bank borrowings and overdrafts13,44210,187
Taxation and social security105,161116,243
Other creditors2,00120,000
Accrued liabilities and deferred income6,3835,782
Total131,342158,573
7.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts19,77530,704
Total19,77530,704
8.Directors advances, credits and guarantees
During the year the directors had loan accounts with the company. At the balance sheet date the directors owed the company a total of £108,294 (2023 - £111,199), interest is paid at the HMRC official rate.
9.Controlling party
This company's parent undertaking and controlling party is Stubbing Nook Nurseries Limited, a company registered in England and Wales, company number 15973139.
10.Description of reasons for any change in chosen formats of the financial statments
The Company has transitioned from FRS 105 to FRS 102 Section 1a reporting requirements this year. The policies applied under the entity's previous accounting framework are not materially different to FRS 102 Section 1a and have not impacted on equity or profit or loss apart from the introduction of a deferred tax asset of £4,200 (£3,300 2023).